Annia Cherrez
Overview
Explore the profile of Annia Cherrez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cherrez-Ojeda I, Robles-Velasco K, Osorio M, Ormaza Vera A, Sarfraz Z, Sarfraz A, et al.
Dermatol Ther (Heidelb)
. 2024 Jun;
14(7):1787-1798.
PMID: 38909171
Introduction: Up to 25% of children and 5.6% of adults in the USA have atopic dermatitis (AD), with substantial impacts on quality of life. Effective control can be challenging despite...
2.
Cherrez-Ojeda I, Bousquet J, Gimenez-Arnau A, Godse K, Krasowska D, Bartosinska J, et al.
J Allergy Clin Immunol Pract
. 2024 May;
12(8):2211-2215.e1.
PMID: 38734372
No abstract available.
3.
Cherrez-Ojeda I, Bousquet J, Gimenez-Arnau A, Godse K, Krasowska D, Bartosinska J, et al.
J Allergy Clin Immunol Pract
. 2024 Apr;
12(6):1575-1583.e1.
PMID: 38604531
Background: Patient-reported outcome measures (PROMs) are validated and standardized tools that complement physician evaluations and guide treatment decisions. They are crucial for monitoring atopic dermatitis (AD) and chronic urticaria (CU)...
4.
Cherrez-Ojeda I, Robles-Velasco K, Osorio M, Mejia-Leiva D, Cherrez A, Cherrez S, et al.
Rev Alerg Mex
. 2023 Mar;
69(1):61-64.
PMID: 36927752
Objetive: To assess cutaneous reactions after Pfizer-BioNTech COVID-19 vaccine administration. Methods: A cross-sectional observational study was carried out in health workers belonging to the city of Guayaquil-Ecuador, from March to...
5.
Cherrez-Ojeda I, Vanegas E, Cherrez A, Felix M, Weller K, Magerl M, et al.
Clin Transl Allergy
. 2021 Dec;
11(10):e12089.
PMID: 34962721
Background: Information/communication technologies such as mobile phone applications (apps) would enable chronic urticaria (CU) patients to self-evaluate their disease activity and control. Yet, recently Antó et al (2021) reported a...
6.
Cherrez-Ojeda I, Maurer M, Felix M, Bernstein J, Ramon G, Criado R, et al.
World Allergy Organ J
. 2021 Sep;
14(8):100577.
PMID: 34471460
Background: Few studies have explored the association between obstructive sleep apnea (OSA) and chronic urticaria (CU). Our study aims to fill this gap by determining the frequency of the risk...
7.
Cherrez-Ojeda I, Vanegas E, Cherrez A, Felix M, Weller K, Magerl M, et al.
World Allergy Organ J
. 2021 Jun;
14(6):100542.
PMID: 34141048
Background: Patients with chronic urticaria (CU) are increasingly using information and communication technologies (ICTs) to manage their health. What CU patients expect from ICTs and which ICTs they prefer remains...
8.
Maurer M, Weller K, Magerl M, Maurer R, Vanegas E, Felix M, et al.
World Allergy Organ J
. 2020 Nov;
13(11):100475.
PMID: 33204387
Background: Chronic urticaria (CU) is characterized by itchy recurrent wheals, angioedema, or both for 6 weeks or longer. CU can greatly impact patients' physical and emotional quality of life. Patients...
9.
Cherrez-Ojeda I, Vanegas E, Mata V, Felix M, Ramon G, Cherrez S, et al.
Allergy Asthma Clin Immunol
. 2019 Apr;
15:25.
PMID: 31019538
Little is known about the association of urticarial vasculitis (UV) with thyroid autoimmunity. The latter has been mostly described in the setting of patients with chronic spontaneous urticaria (CSU). In...
10.
Cherrez-Ojeda I, Maurer M, Bernstein J, Vanegas E, Felix M, Ramon G, et al.
World Allergy Organ J
. 2019 Apr;
12(2):100011.
PMID: 30937137
Background: Updated urticaria guidelines recommend that patients should be assessed for disease activity, severity, control, and quality of life at baseline and follow up. Regarding treatment, guidelines consider second generation...